BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 29298238)

  • 1. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
    Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
    Moris D; Cendales LC
    Front Immunol; 2021; 12():682180. PubMed ID: 34456906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
    Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite Allotransplantation.
    Dzhonova DV; Olariu R; Leckenby J; Banz Y; Prost JC; Dhayani A; Vemula PK; Voegelin E; Taddeo A; Rieben R
    Transplantation; 2018 Oct; 102(10):1684-1694. PubMed ID: 29794937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
    Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
    Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.
    Mathes DW; Chang J; Hwang B; Graves SS; Storer BE; Butts-Miwongtum T; Sale GE; Storb R
    Transplantation; 2014 Jul; 98(2):131-8. PubMed ID: 24918616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful transplantation of kidney allografts in sensitized rats after syngeneic hematopoietic stem cell transplantation and fludarabine.
    Fu Y; Sun Z; Fuchs EJ; Wang Y; Shen ZY; Maeda H; Lin Q; Warren DS; Williams GM; Montgomery RA
    Am J Transplant; 2014 Oct; 14(10):2375-83. PubMed ID: 25139564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice.
    Vernon R; Wang J; Song M; Wilson N; Moris D; Cendales L
    J Surg Res; 2020 Jun; 250():119-124. PubMed ID: 32044508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
    Fries CA; Lawson SD; Wang LC; Slaughter KV; Vemula PK; Dhayani A; Joshi N; Karp JM; Rickard RF; Gorantla VS; Davis MR
    PLoS One; 2019; 14(1):e0210914. PubMed ID: 30677062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata.
    Chandran SR; Mulley WR; Kanellis J; Nikolic-Paterson DJ; Ma FY
    Exp Clin Transplant; 2018 Jun; 16(3):294-300. PubMed ID: 28760115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?
    Sicard A; Kanitakis J; Dubois V; Morelon E; Thaunat O
    Transplantation; 2020 Oct; 104(10):2003-2010. PubMed ID: 32039965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell-derived mesenchymal stem cells prolong hind limb survival in a rat vascularized composite allotransplantation model.
    Mitsuzawa S; Ikeguchi R; Aoyama T; Ando M; Takeuchi H; Yurie H; Oda H; Noguchi T; Ohta S; Zhao C; Ikeya M; Matsuda S
    Microsurgery; 2019 Nov; 39(8):737-747. PubMed ID: 31471984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation.
    Aral AM; Zamora R; Barclay D; Yin J; El-Dehaibi F; Erbas VE; Dong L; Zhang Z; Sahin H; Gorantla VS; Vodovotz Y
    Front Immunol; 2021; 12():591154. PubMed ID: 34017323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft Survival.
    Feturi FG; Zhang W; Erbas VE; Dong L; Sahin H; Zhang Z; Oksuz S; Spiess AM; Solari MG; Venkataramanan R; Gorantla VS
    J Pharm Sci; 2024 Jun; 113(6):1607-1615. PubMed ID: 38309457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.